BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 697433)

  • 1. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
    Wanebo JH; Stearns M; Schwartz MK
    Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Key role of the CEA test in the diagnosis and surgical therapy of recurrent colorectal cancer].
    Quentmeier A; Schlag P; Herfarth C
    Chirurg; 1986 Feb; 57(2):83-7. PubMed ID: 3698741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective monitoring trial for carcinoma of colon and rectum after surgical resection.
    Wanebo HJ; Llaneras M; Martin T; Kaiser D
    Surg Gynecol Obstet; 1989 Dec; 169(6):479-87. PubMed ID: 2683153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.
    Moertel CG; O'Fallon JR; Go VL; O'Connell MJ; Thynne GS
    Cancer; 1986 Aug; 58(3):603-10. PubMed ID: 3731019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of CEA monitoring as a guide to second-look surgery in colorectal cancer follow-up.
    Fucini C; Tommasi MS; Cardona G; Malatantis G; Panichi S; Bettini U
    Tumori; 1983 Aug; 69(4):359-64. PubMed ID: 6623661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?
    Lechner P; Lind P; Goldenberg DM
    J Am Coll Surg; 2000 Nov; 191(5):511-8. PubMed ID: 11085731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen slope analysis as an early indicator for recurrence of colorectal carcinoma.
    Kimura O; Kaibara N; Nishidoi H; Okamoto T; Takebayashi M; Kawasumi H; Koga S
    Jpn J Surg; 1986 Mar; 16(2):106-11. PubMed ID: 3723883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of serial CEA determinations in the early detection of recurrent colorectal cancer.
    Wedell J; Meier zu Esssen P; Luu TH; Fiedler R; van Calker H; Koldowski P; Schlipköter HW
    Dis Colon Rectum; 1981; 24(8):618-21. PubMed ID: 7318628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.
    Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U
    Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.
    Goslin R; Steele G; Macintyre J; Mayer R; Sugarbaker P; Cleghorn K; Wilson R; Zamcheck N
    Ann Surg; 1980 Dec; 192(6):747-51. PubMed ID: 7447529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CEA testing in the post-operative surveillance of colorectal carcinoma.
    Hine KR; Dykes PW
    Br J Cancer; 1984 Jun; 49(6):689-93. PubMed ID: 6733018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols.
    Steele G; Ellenberg S; Ramming K; O'Connell M; Moertel C; Lessner H; Bruckner H; Horton J; Schein P; Zamcheck N; Novak J; Holyoke ED
    Ann Surg; 1982 Aug; 196(2):162-9. PubMed ID: 7046656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-look laparotomy based on CEA elevations in colorectal cancer.
    Attiyeh FF; Stearns MW
    Cancer; 1981 May; 47(9):2119-25. PubMed ID: 7226104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and postoperative uses of CEA.
    Evans JT; Mittelman A; Chu M; Holyoke ED
    Cancer; 1978 Sep; 42(3 Suppl):1419-21. PubMed ID: 709509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer.
    Sugarbaker PH; Zamcheck N; Moore FD
    Cancer; 1976 Dec; 38(6):2310-5. PubMed ID: 1000469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study.
    Minton JP; Hoehn JL; Gerber DM; Horsley JS; Connolly DP; Salwan F; Fletcher WS; Cruz AB; Gatchell FG; Oviedo M
    Cancer; 1985 Mar; 55(6):1284-90. PubMed ID: 3971297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal exploration for suspected recurrent carcinoma of the colon and rectum based upon elevated carcinoembryonic antigen alone or in combination with other diagnostic methods.
    Wilking N; Petrelli NJ; Herrera L; Holyoke ED; Mittelman A
    Surg Gynecol Obstet; 1986 May; 162(5):465-8. PubMed ID: 3704903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of CEA in the early diagnosis of colorectal cancer recurrence in the light of second-look results].
    Colombo PL; Lovotti D; Franco F; Coronelli M; Bonacasa R
    Minerva Med; 1986 Mar; 77(13):495-8. PubMed ID: 3703341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.